-+ 0.00%
-+ 0.00%
-+ 0.00%

Biophytis extends cash runway to Q1 2027 after EUR 2.5 million warrant exercise

PUBT·08/31/2026 07:15:58
Listen to the news
Biophytis extends cash runway to Q1 2027 after EUR 2.5 million warrant exercise
  • Biophytis pushed its cash runway to Q1 2027 following a balance-sheet restructuring.
  • Cash position reached EUR 3 million as of Aug. 31, 2026, supported by EUR 3.7 million gross inflows.
  • Most BSA 2026 warrants were exercised, generating EUR 2.5 million of proceeds at an exercise price of EUR 0.04.
  • Financial debt fell to EUR 2.9 million from EUR 4.27 million, driven by EUR 1.37 million of debt converted into equity.
  • Shares outstanding rose to about 240 million as of Aug. 31, 2026, reflecting warrant exercises and debt-for-equity conversions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biophytis SA published the original content used to generate this news brief on August 31, 2026, and is solely responsible for the information contained therein.